You need to Turn on Javascript or upgrade your Flash Player!

To Fully experience the Rich Media Solutions of this website, you must make sure that JavaScript is enabled.
You may also need to upgrade your Flash Player.

You can upgrade your flash player by
Clicking Here »

 
 
 

Press Release for July 8, 2011 Download

FFF Enterprises Celebrates 23 Counterfeit-Free Years

Biopharmaceutical leader and innovator is a trailblazer in supply chain safety.

Temecula, Calif. – FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals, is commemorating its 23rd anniversary on July 8, 2011. The company celebrates over two decades of counterfeit-free biopharmaceutical distribution, a significant accomplishment since the industry’s supply chain has long been vulnerable to tampering.

FFF Enterprises was founded in 1988 with $100 and a vision to distribute patient examination gloves. Today, the company’s annual sales exceed $1 billion, and its partners include the largest and most influential GPOs, serving over 80 percent of U.S. hospitals and supplying the nation’s leading non-acute care sites. Almost from the start, FFF set out to reshape the biopharmaceutical industry by making the supply chain safer for patients everywhere. This “patients first” philosophy is embodied in the company’s mission of “helping healthcare care.”

“We have always recognized that at the end of every business transaction there is a patient waiting for the product,” states Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc. “Our customers recognize the value of channel integrity to their patients, as well as to their bottom lines. As we continue developing our channel, we expect that responsibility, safety and trust will become the driving values throughout the industry.”

FFF’s commitment to safety is epitomized by numerous innovative technologies such as the Verified Electronic Pedigree (VEP) system, which electronically displays the chain of custody for every product it ships, and the Lot-Track service, which tracks products by lot number and provides recall notification to those affected. The company’s foresight also led to the development of a best practices business model dubbed “The 8 Critical Steps to Guaranteed Channel Integrity.” Another example of FFF’s patient-centered focus is its specialty pharmacy subsidiary, NuFACTOR, which was established to provide IVIG, coagulation factors and vaccines directly to patients. Other innovative programs include MyFluVaccine and VaxAmerica, which have provided revolutionary approaches to vaccination access and administration.

FFF further supports the healthcare community through a broad portfolio of communications, including Flu Awareness Posters, Product Reference Charts, Flu Vaccine Myths and Facts Brochures, a Reimbursement Blog, Interactive Webinars, and the publication of two award-winning magazines, IG Living and BioSupply Trends Quarterly.

With an eye on the future, FFF continues to expand its industry relationships and sphere of influence.

“We have embraced a much more comprehensive relationship with all the stakeholders in healthcare, including patients, providers and payers,” explains Schmidt. “We believe our industry is in a pivotal time of change, and as a result, we are looking at various models that will still meet our end goal: to get the critical-care products we distribute from the manufacturer to the patient in the safest and most efficient way possible.”

About FFF Enterprises, Inc.
Temecula-based FFF Enterprises is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is now in its 24th year with more than a billion dollars in annual sales and a flawless safety track record. FFF has taken a leadership position in regards to supply chain safety and innovation, setting new standards and pioneering industry firsts. FFF’s commitment to Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, with additional steps taken to safely store, handle and ship products to ensure patient safety is never compromised. FFF’s proprietary systems, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel, and FFF’s MyFluVaccine (www.MyFluVaccine.com) and VaxAmerica (www.VaxAmerica.com) are revolutionary vaccination programs that have added a new level of safety, convenience and reliability to both healthcare providers and consumers.

Contact: Cheryl Brooks: (951) 296-2500, ext 1177